India’s cheap birth control pills in US could vanish under Trump’s 250% tariff threat

Donald Trump's tariff threat jeopardizes affordable Indian medicines in the US. Birth control pills, hypertension, and depression treatments are most vulnerable. India, the world's pharmacy, faces potential export losses. Analysts foresee price hikes and supply chain disruptions. Indian firms may struggle to absorb tariffs. The US aims to boost domestic drug production. This move risks higher drug prices for Americans.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GdbjFB0
via IFTTT